Serum Amyloid P Proteins, Antibodies, cDNA Clones Research Reagents

All Serum Amyloid P reagents are produced in house and quality controlled, including 4 Serum Amyloid P Antibody, 39 Serum Amyloid P Gene, 3 Serum Amyloid P Lysate, 3 Serum Amyloid P Protein, 3 Serum Amyloid P qPCR. All Serum Amyloid P reagents are ready to use.
More Less

All Serum Amyloid P Reagents

Serum Amyloid P General Information

Serum Amyloid P Protein (3)

Species

    Serum Amyloid P Antibody (4)

    Application:
    Clonality:
    Host:

      Serum Amyloid P cDNA Clone (39)

      BC007039

      In cloning vector

      In cloning vector

      In expression vector

      untagged

      C-GFPSpark C-OFPSpark C-DDK tag N-DDK tag C-His tag N-His tag C-HA tag N-HA tag C-Myc N-Myc

      In lentiviral vector

      C-GFPSpark
      NM_011318.1

      In cloning vector

      In cloning vector

      In expression vector

      untagged

      C-GFPSpark C-OFPSpark C-DDK tag N-DDK tag C-His tag N-His tag C-HA tag N-HA tag C-Myc N-Myc

      In lentiviral vector

      C-GFPSpark
      NM_017170.2

      In cloning vector

      In cloning vector

      In expression vector

      untagged

      C-GFPSpark C-OFPSpark C-DDK tag N-DDK tag C-His tag N-His tag C-HA tag N-HA tag C-Myc N-Myc

      In lentiviral vector

      C-GFPSpark

      Serum Amyloid P qPCR Primer (3)

      Serum Amyloid P Lysate (3)

        More Product Popular With Customers

        Serum Amyloid P Background

        Serum amyloid P component (SAP) is the identical serum form of amyloid P component (AP), a highly preserved plasma protein named for its ubiquitous presence in amyloid deposits. As a normal plasma protein first identified as the pentagonal constituent of in vivo pathological deposits called "amyloid". Serum amyloid P component represents another member of the pentraxin family, a highly conserved group of molecules that may play a role in innate immunity. SAP is a key negative regulator for innate immune responses to DNA and may be partly responsible for the insufficient immune responses after DNA vaccinations in humans. SAP suppression may be a novel strategy for improving efficacy of human DNA vaccines and requires further clinical investigations.

        Serum Amyloid P References

        • Wang Y, et al. (2011) Human serum amyloid P functions as a negative regulator of the innate and adaptive immune responses to DNA vaccines. J Immunol. 186(5): 2860-70.
        • Hawkins PN. (2002) Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens. 11(6): 649-55.
        • Noursadeghi M, et al. (2000) Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci U S A. 97: 14584-9.
        • de Haas CJ. (1999) New insights into the role of serum amyloid P component, a novel lipopolysaccharide-binding protein. FEMS Immunol Med Microbiol. 26(3-4): 197-202.

        Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.